Current Edition:

Table of Contents :

  In this issue:

Editor’s Note
Neoadjuvant endocrine therapy
Is four cycles of AC adequate adjuvant therapy?
Taxanes in the adjuvant and metastatic setting
Aromatase inhibitors in clinical practice
Combination endocrine therapy
Tamoxifen and quality of life
Long-term survival with metastatic breast cancer
Capecitabine for metastatic disease
Menopause and hormone replacement in breast cancer patients
Pregnancy after breast cancer treatment
Editorial Office

 

 


 
Home · Contact us
Terms of use and general disclaimer
© NL Communications, Inc. 2003. All rights reserved.